Literature DB >> 27587830

Draft Genome Sequence of the Probiotic Yeast Kluyveromyces marxianus fragilis B0399.

Sara Quarella1, Paola Lovrovich2, Simone Scalabrin3, Ilenia Campedelli1, Ana Backovic2, Veronica Gatto1, Federica Cattonaro3, Alessandro Turello2, Sandra Torriani4, Giovanna E Felis1.   

Abstract

Here, we report the draft genome sequence of Kluyveromyces marxianus fragilis B0399, the first yeast approved as a probiotic for human consumption not belonging to the genus Saccharomyces The genome is composed of 8 chromosomes, with a total size of 11.44 Mb, including mitochondrial DNA.
Copyright © 2016 Quarella et al.

Entities:  

Year:  2016        PMID: 27587830      PMCID: PMC5009987          DOI: 10.1128/genomeA.00923-16

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

The probiotic lactic yeast Kluyveromyces marxianus fragilis B0399 (TURVAL B0399) is a strain belonging to a species naturally occurring in kefir and cheese, which is isolated from whey and curds of cow milk. It is the first yeast not belonging to the genus Saccharomyces with probiotic activity that has appeared in the market, and it was approved as a probiotic for both animal feeding (1) and human consumption (2). This strain was shown to remain viable after consumption, surpassing the gastric barrier and colonizing the gut adhering to the enterocytes of the intestinal epithelium (3). Moreover, it regulates intestinal activity during antibiotic therapy, thanks to the yeast intrinsic resistance to bacterium-targeting antibiotics (4). Furthermore, its β-galactosidase activity, absent in strains of the genus Saccharomyces, permits the degradation of lactose, generating glucose and galactose; therefore, it is useful in lowering the effects of lactose intolerance in susceptible individuals (5). Several in vitro (3) and in vivo (4, 6) experimental evidences demonstrated that K. marxianus B0399 is able to modulate the immune response, reducing the proinflammatory cytokine levels, thus being useful for mitigation of the effect of several diseases, such as irritable bowel syndrome (6, 7). Sequencing of its genome was performed to gain more detailed information on its characteristics as a probiotic and to broaden knowledge on the genomic biodiversity in the species K. marxianus, since other strains whose genome sequences are available are used for bioethanol production or other applications (8–10). Microbial DNA, isolated using the Wizard Genomic DNA purification kit (Promega), was used to construct three libraries with insert sizes of 578 nucleotides (nt), 626 nt, and 5 kb, which were amplified and sequenced using the Illumina HiSeq 2000 at IGA Technology Services (Udine, Italy), producing clean data containing 20 million paired reads with 150 nt at 270-fold coverage. Trimmed reads were de novo assembled using AllPaths-LG version 48359 (11) with default parameters, except for TARGETS = Std., HAPLOIDIFY = T, CLOSE_UNIPATH_GAPS=F, DRY_RUN=F, MIN_CONTIG=500, and MAX_MEMORY_GB=120. The contigs were scaffolded using IMR/DENOM version 0.4.0f (12) and ordered by ScaPA release 3 (IGA Technology Services) using the genome of K. marxianus NBRC1777 (GenBank accession numbers AP014599 to AP014607) as a reference. The genome sequence of B0399 was 11.44 Mb, and the G+C content was 40%. The genome was composed of eight chromosomes, including mitochondrial DNA. The assembly generated 109 scaffolds, with a maximum length of 1.3 Mb and an N50 length of 743,117 bases. A total of 5,373 putative proteins of K. marxianus B0399 were predicted using tBLASTn analysis against the reference genome. The key enzyme for lactose degradation (β-galactosidase) was highly similar to the corresponding enzyme from Kluyveromyces lactis, confirming that this yeast can be successfully used for the reduction of the effects of lactose intolerance in susceptible individuals.

Accession number(s).

This whole-genome shotgun project has been deposited at DDBJ/ENA/GenBank under the accession no. LXZY00000000. The version described in this paper is the first version.
  9 in total

1.  High-quality draft assemblies of mammalian genomes from massively parallel sequence data.

Authors:  Sante Gnerre; Iain Maccallum; Dariusz Przybylski; Filipe J Ribeiro; Joshua N Burton; Bruce J Walker; Ted Sharpe; Giles Hall; Terrance P Shea; Sean Sykes; Aaron M Berlin; Daniel Aird; Maura Costello; Riza Daza; Louise Williams; Robert Nicol; Andreas Gnirke; Chad Nusbaum; Eric S Lander; David B Jaffe
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

2.  Potential probiotic Kluyveromyces marxianus B0399 modulates the immune response in Caco-2 cells and peripheral blood mononuclear cells and impacts the human gut microbiota in an in vitro colonic model system.

Authors:  Simone Maccaferri; Annett Klinder; Patrizia Brigidi; Piero Cavina; Adele Costabile
Journal:  Appl Environ Microbiol       Date:  2011-12-09       Impact factor: 4.792

3.  IBS-associated phylogenetic unbalances of the intestinal microbiota are not reverted by probiotic supplementation.

Authors:  Simone Maccaferri; Marco Candela; Silvia Turroni; Manuela Centanni; Marco Severgnini; Clarissa Consolandi; Piero Cavina; Patrizia Brigidi
Journal:  Gut Microbes       Date:  2012-06-20

Review 4.  The yeast Kluyveromyces marxianus and its biotechnological potential.

Authors:  Gustavo Graciano Fonseca; Elmar Heinzle; Christoph Wittmann; Andreas K Gombert
Journal:  Appl Microbiol Biotechnol       Date:  2008-04-22       Impact factor: 4.813

5.  Retrospective observational study to investigate Sinerga, a multifactorial nutritional product, and bacterial extracts in the prevention of recurrent respiratory infections in children.

Authors:  A Nigro; A Nicastro; R Trodella
Journal:  Int J Immunopathol Pharmacol       Date:  2014 Jul-Sep       Impact factor: 3.219

6.  Genomic Sequence of the Yeast Kluyveromyces marxianus CCT 7735 (UFV-3), a Highly Lactose-Fermenting Yeast Isolated from the Brazilian Dairy Industry.

Authors:  Wendel B Silveira; Raphael H S Diniz; M Esperanza Cerdán; María I González-Siso; Robson de A Souza; Pedro M P Vidigal; Otávio J B Brustolini; Emille R B de Almeida Prata; Alexsandra C Medeiros; Lílian C Paiva; Moysés Nascimento; Eder G Ferreira; Valdilene C Dos Santos; Caio R S Bragança; Tatiana A R Fernandes; Lívia T Colombo; Flávia M L Passos
Journal:  Genome Announc       Date:  2014-11-06

7.  Multiple reference genomes and transcriptomes for Arabidopsis thaliana.

Authors:  Xiangchao Gan; Oliver Stegle; Jonas Behr; Joshua G Steffen; Philipp Drewe; Katie L Hildebrand; Rune Lyngsoe; Sebastian J Schultheiss; Edward J Osborne; Vipin T Sreedharan; André Kahles; Regina Bohnert; Géraldine Jean; Paul Derwent; Paul Kersey; Eric J Belfield; Nicholas P Harberd; Eric Kemen; Christopher Toomajian; Paula X Kover; Richard M Clark; Gunnar Rätsch; Richard Mott
Journal:  Nature       Date:  2011-08-28       Impact factor: 49.962

8.  Complete Genome Sequence of Kluyveromyces marxianus NBRC1777, a Nonconventional Thermotolerant Yeast.

Authors:  Kentaro Inokuma; Jun Ishii; Kiyotaka Y Hara; Masao Mochizuki; Tomohisa Hasunuma; Akihiko Kondo
Journal:  Genome Announc       Date:  2015-04-23

9.  Draft Genome Sequence of Kluyveromyces marxianus Strain DMB1, Isolated from Sugarcane Bagasse Hydrolysate.

Authors:  Toshihiro Suzuki; Tamotsu Hoshino; Akinori Matsushika
Journal:  Genome Announc       Date:  2014-07-24
  9 in total
  4 in total

1.  Evaluation of the Potential Probiotic Yeast Characteristics with Anti-MRSA Abilities.

Authors:  Yong Shen; Xue Bai; Yan Zhang; Qian Gao; Xiujuan Bu; Ying Xu; Na Guo
Journal:  Probiotics Antimicrob Proteins       Date:  2022-04-28       Impact factor: 4.609

2.  Oral intake of Kluyveromyces marxianus B0399 plus Lactobacillus rhamnosus CECT 30579 to mitigate symptoms in COVID-19 patients: A randomized open label clinical trial.

Authors:  Vicente Navarro-López; Adriana Hernández-Belmonte; Maria Isabel Pérez Soto; Maikel Ayo-González; Guillermo Losa-Rodríguez; Esther Ros-Sánchez; Maravillas Martínez-Gabarrón; Pedro Sánchez-Pellicer; Juan Aguera-Santos; Eva Núñez-Delegido; Beatriz Ruzafa-Costas; José Antonio Picó-Monllor; Laura Navarro-Moratalla
Journal:  Med Microecol       Date:  2022-08-24

3.  Ploidy Variation in Kluyveromyces marxianus Separates Dairy and Non-dairy Isolates.

Authors:  Raúl A Ortiz-Merino; Javier A Varela; Aisling Y Coughlan; Hisashi Hoshida; Wendel B da Silveira; Caroline Wilde; Niels G A Kuijpers; Jan-Maarten Geertman; Kenneth H Wolfe; John P Morrissey
Journal:  Front Genet       Date:  2018-03-21       Impact factor: 4.599

4.  Screening and characterization of in-vitro probiotic criteria of Saccharomyces and Kluyveromyces strains.

Authors:  Reyhaneh Moradi; Rahim Nosrati; Hamed Zare; Tahereh Tahmasebi; Horieh Saderi; Parviz Owlia
Journal:  Iran J Microbiol       Date:  2018-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.